IFNG and neoplasm: ILC1s mainly exert anti-tumour activity, indeed, ILC1-derived IFN-γ can contribute indirectly to anti-tumoural immunity by recruiting and activating effector immune cells through the cytokine production, upregulation of co-stimulatory molecules and cytotoxicity [170,174].